BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1840201)

  • 1. Acute, chronic and postwithdrawal antihypertensive and renal effects of amlodipine in hypertensive patients.
    Leonetti G; Rupoli L; Chianca R; Catarrasi C; Ruffilli MP; Zanchetti A
    J Hypertens Suppl; 1991 Dec; 9(6):S394-5. PubMed ID: 1840201
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal clearance and micropuncture studies of nisoldipine effects in spontaneously hypertensive rats.
    Giebisch G; Guckian VA; Klein-Robbenhaar G; Klein-Robbenhaar MT
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S24-31. PubMed ID: 2441180
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
    Ruilope LM; Miranda B; Garcia-Robles R; Bigorra J; Oliet A; Alcazar JM; Sancho Rof J; Rodicio JL
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):90-3. PubMed ID: 2468941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine in the treatment of hypertension.
    Kaplan NM
    Postgrad Med J; 1991; 67 Suppl 5():S15-9. PubMed ID: 1839432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine].
    Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M
    Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state.
    Reams GP; Lau A; Hamory A; Bauer JH
    Am J Kidney Dis; 1987 Dec; 10(6):446-51. PubMed ID: 2961256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 15. Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor.
    Malacco E; Fogari R; Tettamanti F; Magenta M
    J Hypertens Suppl; 1991 Dec; 9(6):S372-3. PubMed ID: 1840198
    [No Abstract]   [Full Text] [Related]  

  • 16. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.